Butyryl-Carnitine

Butyryl-Carnitine

SCHEMBL25274079

CC(C)C(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.CCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.68
▸ MAPK1 P28482 4/20 0.66
▸ LMNA P02545 4/20 0.66
▸ MAPT P10636 4/20 0.66
▸ MEN1 O00255 4/20 0.66
▸ KMT2A Q03164 4/20 0.66
▸ GMNN O75496 3/20 0.66
▸ NPSR1 Q6W5P4 3/20 0.66
▸ TP53 P04637 3/20 0.66
▸ TSHR P16473 3/20 0.66
▸ HSP90AA1 P07900 2/20 0.66
▸ BLM P54132 2/20 0.66
▸ NR1H4 Q96RI1 2/20 0.66
▸ CYP2C9 P11712 2/20 0.66
▸ HIF1A Q16665 2/20 0.66
▸ GLA P06280 1/20 0.64
▸ PMP22 Q01453 1/20 0.64
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ SLC25A20 O43772 3/20 0.50
▸ CYP2D6 P10635 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyryl-Carnitine SCHEMBL12137158 0.91 CYP1A2 (0.79) CYP1A2MAPK1LMNAMAPTMEN1
Butyryl-Carnitine SCHEMBL12283483 0.91 CYP1A2 (0.79) CYP1A2MAPK1LMNAMAPTMEN1
Butyryl-Carnitine SCHEMBL3902301 0.90 CYP1A2 (0.77) CYP1A2MAPK1LMNAMAPTMEN1
Butyryl-Carnitine SCHEMBL28712507 0.90 CYP1A2 (0.77) CYP1A2MAPK1LMNAMAPTMEN1
SCHEMBL12137159 0.88 LMNA (0.66) CYP1A2MAPK1LMNAMAPTMEN1
SCHEMBL12152164 0.88 LMNA (0.66) CYP1A2MAPK1LMNAMAPTMEN1
SCHEMBL25099265 0.88 LMNA (0.66) CYP1A2MAPK1LMNAMAPTMEN1
Bromide SCHEMBL2995962 0.86 LMNA (0.64) CYP1A2MAPK1LMNAMAPTMEN1
Hydrochloric Acid SCHEMBL8752462 0.86 LMNA (0.69) CYP1A2MAPK1LMNAMAPTMEN1
Butyryl-Carnitine SCHEMBL28900547 0.85 CYP1A2 (0.71) CYP1A2MAPK1LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190709-A1 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS MarvelBiome, Inc. (US) 2023-06-22 — — US disclosed
Send feedback